Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceará, 60430-140, Fortaleza, CE, Brazil.
Naunyn Schmiedebergs Arch Pharmacol. 2012 Oct;385(10):981-90. doi: 10.1007/s00210-012-0778-3. Epub 2012 Jul 14.
Oral mucositis is an important dose-limiting and costly side effect of cancer chemotherapy. Soluble proteins obtained of the latex of Calotropis procera have been extensively characterized as anti-inflammatory in different experimentally induced inflammatory conditions, including arthritis and sepsis. In this study, the phytomodulatory laticifer proteins (LP) were challenged to regress the inflammatory events associated with 5-fluorouracil-induced oral mucositis. We also evaluated the expression of pro-inflammatory cytokines and inducible enzymes, such as cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS). Oral mucositis was induced in hamsters by two injections of 5-fluorouracil (5-FU; 60 and 40 mg/kg, i.p., on experimental days 1 and 2, respectively). LP (5 mg/kg, i.p.) was injected 24 h before and 24 h after mechanical trauma of the cheek pouches. A normal control group received only saline. On day 10, the animals were sacrificed, and the cheek pouches were excised for macroscopic and histopathological analysis, myeloperoxidase activity measurement, and immunohistochemical assessment of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), iNOS, and COX-2. LP significantly inhibited macroscopic histopathological scores and myeloperoxidase activity compared with the 5-FU control group. 5-Fluorouracil also induced marked immunostaining of TNF-α, IL-1β, iNOS, and COX-2 on inflamed conjunctive and epithelial tissue compared with the normal control group. Such damage was significantly inhibited (p < 0.05) by LP treatment compared with the 5-FU group. These findings demonstrate an anti-inflammatory effect of LP on 5-FU-induced oral mucositis. The protective mechanism appears to involve inhibition of the expression of iNOS, COX-2, TNF-α, and IL-1β.
口腔黏膜炎是癌症化疗的一个重要剂量限制和昂贵的副作用。从牛奶草(Calotropis procera)的乳胶中获得的可溶性蛋白质已被广泛表征为在不同的实验性炎症条件下具有抗炎作用,包括关节炎和败血症。在这项研究中,植物调节乳汁蛋白(LP)被用于对抗 5-氟尿嘧啶引起的口腔黏膜炎相关的炎症事件。我们还评估了促炎细胞因子和诱导型酶(如环氧化酶-2(COX-2)和诱导型一氧化氮合酶(iNOS))的表达。通过两次注射 5-氟尿嘧啶(5-FU;分别在实验第 1 天和第 2 天以 60 和 40mg/kg,ip 给予)在金黄地鼠中诱导口腔黏膜炎。LP(5mg/kg,ip)在机械性创伤颊囊之前 24 小时和之后 24 小时给予。正常对照组仅接受生理盐水。第 10 天,处死动物,切除颊囊进行大体和组织病理学分析、髓过氧化物酶活性测定以及肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)、iNOS 和 COX-2 的免疫组织化学评估。与 5-FU 对照组相比,LP 显著抑制了大体组织病理学评分和髓过氧化物酶活性。与正常对照组相比,5-FU 还诱导了炎症性结合和上皮组织中 TNF-α、IL-1β、iNOS 和 COX-2 的显著免疫染色。与 5-FU 组相比,LP 治疗显著抑制了这种损伤(p<0.05)。这些发现表明 LP 对 5-FU 诱导的口腔黏膜炎具有抗炎作用。保护机制似乎涉及抑制 iNOS、COX-2、TNF-α和 IL-1β 的表达。
Naunyn Schmiedebergs Arch Pharmacol. 2012-7-14
Cancer Chemother Pharmacol. 2007-4
Cancer Chemother Pharmacol. 2010-7-27
Braz J Med Biol Res. 2019-2-25
Cancer Chemother Pharmacol. 2008-2
Plants (Basel). 2021-6-30
Antioxidants (Basel). 2020-9-7
Naunyn Schmiedebergs Arch Pharmacol. 2016-7
Mediators Inflamm. 2014
Naunyn Schmiedebergs Arch Pharmacol. 2012-5
Cancer Chemother Pharmacol. 2011-5-5
Cancer Chemother Pharmacol. 2010-7-27
Naunyn Schmiedebergs Arch Pharmacol. 2010-6-3
Radiother Oncol. 2009-7-1